transcriptomics

Improved chemistry may make RNA editing therapies more feasible in humans.

Following innovations in amplification and scaling over the past 30 years, single cell sequencing technologies have permeated all corners of biomedical research, providing cellular insights into diseases such as heart failure or the immune response during COVID-19 infection.

Researchers pioneered a new strategy for diagnosing puzzling genetic diseases, expanding scientists’ capability to study their causes and pathophysiology.

LIVE December 16th, 2021 at 1:00 PM ET
How stress causes the brain to respond differently to opioids in males and females.

LIVE October 28th, 2021 at 10:30 AM ET
Deconstructing neuroanatomical pathways and cellular heterogeneity in the brain using single cell sequencing

Machine learning paired with single-cell analysis helps scientists identify pathways that cause disease and potential therapeutics.

A special report on cancer. The work led to a better understanding of the roles of tertiary lymphoid structures in cancer and its response to immunotherapy.

ConserV Bioscience and eTheRNA immunotherapies collaborate on mRNA vaccines for infectious diseases

Download this eBook from Drug Discovery News to learn about leading immunotherapy drugs in the pipeline and discover new approaches to immunotherapy drug discovery and delivery.

OliX Pharmaceuticals spins out new subsidiary for developing mRNA vaccines and therapeutics